Nutrien Ltd. (NYSE:NTR) Given Average Rating of "Hold" by Analysts

Key Points

• Consensus "Hold": Twenty analysts cover Nutrien with a consensus rating of Hold (2 sell, 8 hold, 10 buy) and an average 1‑year price target of about $79.65.
• Analyst views are mixed: Wells Fargo and CIBC raised targets and upgraded/maintained bullish ratings (Wells Fargo to Overweight with a $100 target; CIBC to $90), while Zacks cut near‑term estimates and lowered its rating to Hold; the company also missed the quarter on EPS ($0.83 vs. $0.87) and revenue.
• Market reaction and signals: shares opened at $70.64 and fell about 5.2%, accompanied by unusually large put buying (~14,187 contracts, ~88% above average) indicating heightened hedging or bearish bets; Nutrien also raised its quarterly dividend to $0.55 (annualized $2.20, ~3.1% yield).

Shares of Nutrien Ltd. (NYSE:NTR - Get Free Report) have been given a consensus rating of "Hold" by the twenty analysts that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and ten have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $79.6471.

Several research analysts recently issued reports on NTR shares. Zacks Research lowered shares of Nutrien from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 2nd. Canadian Imperial Bank of Commerce increased their price target on shares of Nutrien from $81.00 to $90.00 and gave the stock an "outperformer" rating in a research note on Tuesday, March 17th. Scotiabank increased their price target on shares of Nutrien from $63.00 to $70.00 and gave the stock a "sector perform" rating in a research note on Monday, February 2nd. Mizuho increased their price target on shares of Nutrien from $65.00 to $68.00 and gave the stock a "neutral" rating in a research note on Friday, January 16th. Finally, Wells Fargo & Company upgraded shares of Nutrien from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $77.00 to $100.00 in a research note on Friday, March 13th.

Key Nutrien News

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks raised a couple of near‑term quarter forecasts (Q3 2026 to $0.75 from $0.72; Q2 2027 to $1.87 from $1.84), which slightly offsets cuts elsewhere and could support near‑term earnings visibility. MarketBeat Zacks upgrades
• Neutral Sentiment: Mizuho reiterated a Hold on NTR (reported as “Gets a Hold”), a neutral signal that suggests no immediate change in sell‑side conviction. Nutrien (NTR) Gets a Hold from Mizuho Securities
• Negative Sentiment: Unusually large put buying: traders purchased ~14,187 put contracts on Friday (about 88% above the average put volume), signaling increased hedging or directional bearish bets that can amplify downside pressure on the stock. Options flow report
• Negative Sentiment: Zacks Research issued a string of downward revisions across multiple periods — trimming EPS for Q2 2026, Q4 2026, Q1 2027, Q4 2027 and lowering FY2026–FY2028 estimates (while keeping a Hold rating). The cuts reduce near‑ and medium‑term earnings expectations and likely prompted some investor selling. Zacks still cites a consensus full‑year figure (reported there) but has lowered several company forecasts. MarketBeat — Zacks estimate revisions

Nutrien Stock Down 5.2%

Shares of NYSE NTR opened at $70.64 on Friday. The company has a current ratio of 1.34, a quick ratio of 0.70 and a debt-to-equity ratio of 0.37. Nutrien has a 12 month low of $51.98 and a 12 month high of $85.36. The firm has a market capitalization of $33.96 billion, a PE ratio of 15.16 and a beta of 0.69. The firm has a fifty day simple moving average of $74.53 and a two-hundred day simple moving average of $65.70.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a return on equity of 8.41% and a net margin of 8.43%.The firm's revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.31 earnings per share. Equities analysts expect that Nutrien will post 3.72 earnings per share for the current year.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st were paid a dividend of $0.55 per share. The ex-dividend date was Tuesday, March 31st. This represents a $2.20 dividend on an annualized basis and a yield of 3.1%. This is an increase from Nutrien's previous quarterly dividend of $0.55. Nutrien's dividend payout ratio (DPR) is 47.21%.

Institutional Trading of Nutrien

A number of institutional investors have recently made changes to their positions in NTR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Nutrien by 65.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,224 shares of the company's stock valued at $1,253,000 after acquiring an additional 9,950 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in shares of Nutrien by 6.2% during the 1st quarter. NewEdge Advisors LLC now owns 6,907 shares of the company's stock valued at $343,000 after acquiring an additional 404 shares during the last quarter. Focus Partners Wealth purchased a new stake in shares of Nutrien during the 1st quarter valued at about $516,000. Acadian Asset Management LLC purchased a new stake in shares of Nutrien during the 1st quarter valued at about $54,000. Finally, Prudential Financial Inc. purchased a new stake in shares of Nutrien during the 2nd quarter valued at about $203,000. Hedge funds and other institutional investors own 63.10% of the company's stock.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.